US EditionHims & Hers to offer at-home blood draws and lab testing with new acquisition
- Hims & Hers Health has acquired Trybe Labs, enabling at-home blood draws and lab testing for its users.
- The acquisition aims to provide competition to services like Labcorp and Quest Diagnostics, according to Hims & Hers.
- Dr. Patrick Carroll stated that richer data from tests will enhance clinical decisions for patients.
- Hims & Hers plans to roll out the new testing services within the next year.
11 Articles
11 Articles
Hims & Hers stock surges 23%: Telehealth company announces expansion into blood testing weeks after Super Bowl buzz
Amid a month of skyrocketing stock prices and unprecedented social media buzz, Hims & Hers is expanding its territory into at-home blood testing and diagnostics. Hims has acquired at-home lab testing facility Trybe Labs, the telehealth company said Wednesday. Using at-home blood draws, Hims will now offer over 70 at-home diagnostics tests, ranging from heart health to certain cancer detection tests. All these can be arranged through the app, wit…
The 'miraculous' Ozempic doesn't fit every pocket. In the USA, those who do not have at least partial health insurance coverage spend an average of US$ 936 a month on the drug. The telemedicine startup Hims & Hers Health saw an opportunity to boost its business, based on subscription plans for medical treatments. Semaglutide, the active ingredient in Ozempic and Wegovy, is still under patent protection, which belongs to the Danish company Novo N…
Coverage Details
Bias Distribution
- 40% of the sources lean Left, 40% of the sources are Center
To view factuality data please Upgrade to Premium
